期刊文献+

加强血液科进修生急性放射病救治培养

下载PDF
导出
摘要 急性放射病是机体在短期内受到大剂量电离辐射照射引起的全身性疾病。随着科学技术的发展,放射线技术已经广泛应用于工农业、医学和科学研究等领域,为人类做出了很大的贡献,但如果设备失灵或管理不当,就会造成人员伤亡。另外,一旦发生核事故,将不可避免的发生急性放射病。
出处 《现代医药卫生》 2010年第19期3030-3031,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献8

  • 1闵锐,潘真,李雨.急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二[J].国外医学(放射医学核医学分册),2005,29(6):272-278. 被引量:6
  • 2蒋本荣,艾辉胜,叶根耀,李国民,姚波.外照射急性放射病临床诊治中面临的一个重要课题[J].中华放射医学与防护杂志,2007,27(1):43-46. 被引量:8
  • 3余长林,乔建辉,郭梅,王丹红,孙琪云,张石,姜维浩,张锡刚,王浩春,陈艳琴,艾辉胜.单倍体外周血造血干细胞移植治疗肠型急性放射病[J].解放军医学杂志,2007,32(5):437-440. 被引量:5
  • 4Ballen KK, Colvin G, Dey BR,et al.Cellular immune therapy for refractory cancers: novel therapeutic strategies[J].Exp Hematol, 2005,33(12)1427.
  • 5Cutler C ,Antin JH. An overview of hematopoietic stem cell transplantation[J]. Clin Chest Med, 2005,26(4) :517.
  • 6Rubio MT,Zhao G,Buchli J,et al. Role of indirect allo- and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions(RLI) in mixed chimeras prepared with nonmyeloablative conditioning[J].Clin hnmunol, 2006,120(1) : 33.
  • 7Terlizz SD ,Zino E, Mazz B,et al. Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations[J].Biol Blood Marrow Transplant, 2006,12(1):95.
  • 8Chen X,Zhang C ,Zhang X ,et al. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies[J]. Biol Blood Marrow Transplant,2009,15(4): 266.

二级参考文献26

  • 1艾辉胜,余长林,乔建辉,郭梅,张石,王丹红,孙琪云.异基因外周血造血干细胞移植治疗极重度骨髓型和肠型急性放射病的临床报告[J].解放军医学杂志,2007,32(4):287-288. 被引量:19
  • 2姚波,蒋本荣,贾蜀琼,满秋红,邱立娟,艾辉胜.胞浆分裂阻滞微核法对山东“10·21”辐射事故病人受照射剂量的估算[J].解放军医学杂志,2007,32(4):293-295. 被引量:5
  • 3余长林,乔建辉,郭梅,张石,王丹红,姜维浩,葛飞娇,张锡刚,王浩春,陈艳琴,艾辉胜.急性放射病异基因外周血造血干细胞移植后的免疫重建[J].解放军医学杂志,2007,32(4):296-298. 被引量:3
  • 4National council on Radiation Protection and Measurements.Management of Terrorist Events Involving Radioactive Material.NCRP Report No. 138 [C]. Bethesda, MD, 2001. 125-134.
  • 5U.S. Department of Health and Human Services, U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance:Potassium iodide as a thyroid blocking agent in radiation emergencies. December 2001. www.fda.gov/cder/guidance/4825fnl.pdf.
  • 6Bedell C. Pegfilgrastim for chemotherapy-induced neutropenia [J].Clin J Oncol Nurs, 2003, 7(1): 55-56.
  • 7Holmes FA, O'Shaughnessy JA, Vukelja S, et al. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage Ⅱ or stage Ⅲ/Ⅳ breast cancer [J]. J Clin Oncol, 2002, 20(3): 727-731.
  • 8Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions [J]. JAMA, 2003, 289(15): 1941-1949.
  • 9Blajchman MA. Immunomodulation and blood transfusion [J]. Am J Ther, 2002, 9(5):389-395.
  • 10Maekawa K. Overview of medical care for highly exposed victims in the Tokaimura accident [A]. Ricks RC, Berger ME, O'Hara FM, eds.The Medical Basis for Radiation Accident Preparedness: The Clinical Care of Victims [C]. New York: Parthenon, 2002.313-318.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部